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Abstract: Primary cutaneous marginal zone lymphoma (PCMZL) is one of the most common cutaneous
B-cell lymphomas. It affects mostly patients in their fourth decade and manifests with multifocal nodules
mostly on the arms and upper trunk in more than half of the patients. PCMZL is, however, rare in children
and adolescents, with only 20 cases reported in patients aged 20 and younger. The authors present 3 cases
of PCMZL in teenagers. The patients were 2 girls aged 18 and 13 and a 17-year-old boy. Two patients
presented with multiple lesions involving various anatomic sites, whereas in 1 patient, 2 small closely
opposed papules on the abdomen were seen. Histopathologically, the characteristic appearance of PCMZL
was found in 3 of 4 specimens, with nodular infiltrates composed of small lymphocytes in the interfollicular
compartment, reactive germinal centers, and plasma cells in small clusters mainly at the periphery of the
infiltrates, whereas 1 specimen showed a dense lymphocytic infiltrate with small granulomas. Clonality
was demonstrated by monotypic immunoglobulin light chain expression and/or monoclonal rearrangement
of the immunoglobulin heavy chain genes. No Borrelia burgdorferi was identified on serology or by
polymerase chain reaction in any of the cases. Treatment included excision or administration of antibiotics
with complete remission in all the 3 patients indicating that PCMZL in children and young adolescents
follows the same indolent course with a tendency for recurrences, but excellent prognosis as in adults.
The pertinent literature on PCZL in childhood and adolescence is reviewed.
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Abstract: Primary cutaneous marginal zone lymphoma (PCMZL)
is one of the most common cutaneous B-cell lymphomas. It affects
mostly patients in their fourth decade and manifests with multifocal
nodules mostly on the arms and upper trunk in more than half of the
patients. PCMZL is, however, rare in children and adolescents, with
only 20 cases reported in patients aged 20 and younger. The authors
present 3 cases of PCMZL in teenagers. The patients were 2 girls
aged 18 and 13 and a 17-year-old boy. Two patients presented with
multiple lesions involving various anatomic sites, whereas in 1
patient, 2 small closely opposed papules on the abdomen were seen.
Histopathologically, the characteristic appearance of PCMZL was
found in 3 of 4 specimens, with nodular inﬁltrates composed of small
lymphocytes in the interfollicular compartment, reactive germinal
centers, and plasma cells in small clusters mainly at the periphery of
the inﬁltrates, whereas 1 specimen showed a dense lymphocytic
inﬁltrate with small granulomas. Clonality was demonstrated by
monotypic immunoglobulin light chain expression and/or mono-
clonal rearrangement of the immunoglobulin heavy chain genes. No
Borrelia burgdorferi was identiﬁed on serology or by polymerase
chain reaction in any of the cases. Treatment included excision or
administration of antibiotics with complete remission in all the 3
patients indicating that PCMZL in children and young adolescents
follows the same indolent course with a tendency for recurrences, but
excellent prognosis as in adults. The pertinent literature on PCZL in
childhood and adolescence is reviewed.
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INTRODUCTION
Primary cutaneous marginal zone lymphoma (PCMZL)
represents an indolent B-cell lymphoma composed of small
B cells, marginal zone cells, lymphoplasmacytoid cells, and
mature plasma cells.1,2 It affects mostly patients in their fourth
decade and usually manifests with multifocal nodular lesions
(up to 3 cm), most commonly located on the trunk and
arms.3,4 PCMZL is histologically characterized by dermal
conﬂuent nodular lymphocytic inﬁltrates composed of small
lymphocytes, lymphoplasmacytoid cells, mature plasma cells,
and reactive germinal centers with tingible body macro-
phages.5 Predominance of monocytoid B cells instead of lym-
phoplasmacytic cells or plasma cells is occasionally seen.6
PCMZL is rare in children and adolescents with only 20 cases
reported in patients aged 20 and younger. Here we present 3
cases of pediatric PCMZL and review the previously pub-
lished cases.
MATERIALS AND METHODS
Three patients with PCMZL are the subjects of this
report. Four biopsies were available for histopathological and
molecular analysis. In all cases, routine light microscopy,
immunohistochemical studies, and molecular biologic studies
(IgH rearrangements) were performed.7
RESULTS
Clinical Data
The main features are summarized in Table 1. The
patients were 2 teenager girls aged 13 and 18 years and
a 17-year-old male patient. Two patients presented with mul-
tiple lesions involving various anatomic sites on the arms, the
upper trunk, and the face (patients 1 and 3), whereas in
1 patient, 2 small closely opposed papules were present on
the lower abdomen (patient 2) (Figs. 1, 2). The history was
unremarkable concerning other skin diseases and autoimmune
disorders. The male patient (patient 3) was known to have
been taking methylphenidate for attention-deﬁcit hyperactiv-
ity syndrome for 2 years before the occurrence of PCMZL.
Remarkably, on withdrawal of the medicine, some of the
lesions spontaneously regressed. Surgical excision of at least
one of the lesions was performed in all patients. In patient 3, 2
of the lesions were treated with intralesionally applied inter-
feron alpha (3 injections of 3 Mio IU per week) resulting in
complete remission. In patient 1, treatment with doxycy-
cline (100 mg twice per day for 14 days) resulted in partial
regression of the lesions; during the course of the disease,
additional nodules appeared on both arms and the back. At
the last follow-up examination, she was alive with disease
(Figs. 1, 2).
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Histopathological, Immunohistochemical,
and Molecular Biologic Data
Four specimens were available for the studies (2 biopsies
were available from patient 2). In 3 specimens, there was
a diffuse, nodular, or multinodular dermal inﬁltrate displaying
lymphoid follicles with reactive germinal centers, either
conﬂuent or separated one from another (Figs. 3A, 4A). In
the interfollicular inﬁltrate, small well-differentiated lympho-
cytes and lymphoid cells with clear cytoplasm were present
(Figs. 3B, 4B). Numerous plasma cells often forming collec-
tions at the periphery of the inﬁltrate were found (Fig. 4B).
Overall, the inﬁltrate was predominantly composed of
B cells (CD20, CD79a) with a variable number of reactive
T cells (CD3) accounting for up to 30% of the inﬁltrate. The
regular networks of follicular dendritic cells were highlighted
by CD21 (Fig. 3C). As demonstrated by in situ hybridization,
plasma cells were monotypic, with the restriction of the Ig
lambda in case 3 (Figs. 3D, E), and Ig light chain kappa in
cases 1 and 2 (kappa:lambda ratio 10:1 and 5:1, respectively)
(Figs. 4C, D). IgG4 was negative in all 3 cases. In 2 cases,
there were small collections of CD123-positive plasmacytoid
dendritic cells.
The second specimen from patient 2 manifested
a diffuse inﬁltrate composed almost exclusively of plasma
cells admixed with few epithelioid histiocytes, focally
forming small granulomas (Fig, 4B). Occasional multinu-
cleated cells were present. At the periphery of the inﬁltrate,
plasma cells were arranged in a single ﬁle pattern between
somewhat thickened collagen ﬁbers resembling a scar.
The plasma cells manifested monoclonal restriction of
the kappa light chain, as in the other specimen from
this patient with a more conventional appearance of the
lymphoma.
Monoclonal IgH rearrangement was found in 2 of the 3
studied specimens (cases 1 and 3). No Borrelia burgdorferi
DNA was identiﬁed in all 3 cases studied by nested PCR.
Serologic assays for B. burgdorferi was negative in all 3
patients (Table 1).
TABLE 1. Clinicopathological Features of 3 Pediatric Patients With Primary Cutaneous Marginal Zone Lymphoma





1 F/18 Multiple nodules in the trunk and arms,
partial spontaneous regression. Clinical
DDx: LyP?
Ig k + /IgH+ 2/2 Excision, Doxycycline
2 · 100 mg for 2 wk
PR, AWD, 9 mo
2 F/13 Two closely opposed erythematous
papules on the abdomen. Clinical
DDx: Molluscum contagiosum?
Ig k + /IgH2 2/2 Excision NED, 12 mo
3 M/17 6-year history of nodules on both arms
and face




AWD, alive with disease; DDx, differential diagnosis; ICH, immunohistochemistry; IFN, interferon alpha; LyP, lymphomatoid papulosis; NED, no evidence of disease; ND, not
done; PCR, polymerase chain reaction.
FIGURE 1. Plaques on the left shoul-
der (A) and left arm (B) in patient 1.
FIGURE 2. Nodular lesion on the chest in patient 3.
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FIGURE 3. Multinodular infiltrate extending into the deep dermis (A) (H&E, magnification ·2.5). The infiltrate is composed of small
lymphocytes, some with clear cytoplasm (B) (H&E, magnification ·200). Networks of CD21-positive follicular dendritic cells (C)
(immunohistochemistry, magnification ·200). Expression of immunoglobulin light chains (D: lambda; E: kappa) with monoclonal
expression of Ig light chain lambda (D) (in situ hybridization, magnification ·2.5).
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DISCUSSION
Primary cutaneous B-cell lymphomas rarely occur in
children. Secondary cutaneous involvement by immature
B-cell lymphoblastic lymphoma is not uncommon, whereas
primary low-grade B-cell lymphoma, particularly PCMZL, is
very rare in this age group. Fink-Puches et al,8 who evaluated
a series of 69 patients younger than 20 years with cutaneous
lymphomas, found 7 patients with PCMZL (2 male and 5
female), with a mean age of 17 years (range, 12–20 years).
Three cases of pediatric PCMZL (2 girls and 1 boy) have been
reported by Amitay-Laish et al,9 with all 3 patients manifesting
multiple lesions. In 2 patients, the disease demonstrated
a chronically relapsing course showing residual disease at 63
and 54 months of follow-up, respectively. An unusual clinical
presentation with a 6-month history of waxing and waning
erythematous papules on the limbs was reported by Sharon
et al10 in one of their 2 PCMZL cases. This 12-year-old boy
was initially treated by oral doxycycline combined with topical
0.05% clobetasol cream but developed new lesions that were
treated with topical nitrogen mustard. A similar treatment com-
bined with surgical excision was chosen for the second patient
of the authors.10
In addition to these small series, few pediatric cases of
PCMZL were described as isolated case reports. Zambrano
et al11 documented a 14-year-old boy with a PCMZL on the
lip. A case of pediatric PCMZL in an 11-year-old boy treated
with rituximab was described by Park et al.12 Cozzio et al13
used intralesional low-dose interferon a2 for their 19-year-old
male patient. Apparently, the ﬁrst case of PCMZL from the
USA has been documented by Sroa and Magro14 who
described a 15-year-old boy with one lesion. Dargent et al15
reported an 11-year-old boy with PCMZL presenting with
a solitary tumor on the head who was successfully treated
by surgery alone. A trisomy 3 was detected on 14% of the
neoplastic cells by FISH. Trisomy 3 is the most frequent
chromosomal aberration seen in this type of lymphoma in
adult patients, with approximately 20% of studied cases dis-
playing this anomaly, either singly or in combination with
t(14;18)(q32;q21) or t(3;14)(p14.1;q32).16–18 Most recently,
a 15-year-old boy with multiple lesions representing PCMZL
and juxta-articular ﬁbrotic nodules showing on histology nod-
ular sclerosis with peripheral plasma cell–rich inﬁltrates or
features reminiscent of quiescent lesions of chronic localized
ﬁbrosing leukocytoclastic vasculitis.19 Remarkably, so far all
pediatric patients with PCMZL were older than 10 years, ie,
in the puberty or adolescence.
The differential diagnosis of PCMZL in children
includes Borrelia-associated lymphocytoma cutis, which
mostly affects the ear lobes, nipples, and scrotum in children
and presents with a solitary lesion in most patients, which
contrasts to the multifocal lesions in the majority of
PCMZL.20,21 The so-called lymphoplasmacytic plaque
FIGURE 4. Diffuse and nodular infiltrate predominantly in the upper and mid dermis (A) (H&E, magnification ·2.5). The infiltrate
contains small lymphocytes, numerous plasma cells, and histiocytes (B) (H&E, magnification ·200). Expression of immunoglobulin
light chains (C: lambda; D: kappa) with monoclonal expression of Ig light chain kappa (D) (in situ hybridization, magnification ·25).
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usually favors the pretibial area.22–24 Cutaneous plasmacytosis
and plasmacytoma are also differential diagnostic consider-
ation, although the latter is viewed in the current cutaneous
lymphoma classiﬁcations as a variant of MZL.25,26
A subset of adult cases of PCMZL has been associated
with B. burgdorferi infection in Europe, but not in the USA
and Asia. With respect to pediatric cases, B. burgdorferi was
identiﬁed by PCR in one of the 7 cases reported by Fink-
Puches et al8 and by indirect immunoﬂuorescence and Western
blot tests in the case described by Park et al.12 In the patient
reported by Ghatalia et al,19 Borrelia PCR and serology were
negative but immunohistochemistry using a modiﬁed method
of focus-ﬂoating microscopy yielded spirochete-like forms. In
our series, no association with Borrelia sp. was detected.
Remarkably, in patient 1, a partial response to antibiotic treat-
ment was observed indicating that other bacteria than Borrelia
sp. may be involved in the pathogenesis of PCMZL.
Guitart and Gerami27 suggested that some cases re-
ported as PCMZL in children and young adults characterized
by an indolent course with spontaneous remission and l light-
chain restriction may in fact represent marginal zone hyperpla-
sia of the skin, a poorly deﬁned condition at present analogous
to atypical marginal zone hyperplasia of mucosa-associated
lymphoid tissue (MALT) as found in the appendix and ton-
sils.28 Although some lesions in our cases were small, suggest-
ing an incipient disease, there was restriction of k light chains.
Brenner et al29 have recently demonstrated IgG4
expression in a signiﬁcant subset of PCMZL with plasmacytic
differentiation. None of the patients with IgG4 positive
PCMZL had a preexisting systemic IgG4-related disease, sug-
gesting a localized immunologic IgG4-driven process at an
early stage of the disease. Interestingly, more than one third of
their IgG4 cases demonstrated oligoclonal/polyclonal IgH
rearrangement patterns. In none of our 3 cases tested were
IgG4 cells present. This may be explained by a small study
sample, but age-dependent differences cannot be totally dis-
carded, because the study by Brenner et al29 included only
adult cases.
In conclusion, we have reported 3 pediatric cases of
PCMZL. Taking into account the 20 heretofore published cases
and our experience, it can be summarized that pediatric
PCMZL show no gender predilection (12 male and 11 female),
presents in approximately one third of cases (7/23) with lesions
involving .1 anatomic site, and persistent disease occurs in
a minority of instances (4/23). Association with B. burgdorferi
is rare (4/23) but as with adult disease, geographic variation
may be a factor. The course of pediatric PCMZL follows the
indolent course and excellent prognosis as it is known from this
lymphoma entity in adults.
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